Oriola-KD Oyj - Company Announcement

Oriola-KD Corporation to Sell its Healthcare Trade Business to Mediq N.V.

Oriola-KD Corporation Stock Exchange Release 12 May 2010 at 9.00 a.m.

Oriola-KD Corporation has signed an agreement to sell its Healthcare Trade
businesses to the stock listed Dutch company Mediq N.V., international provider
of pharmaceuticals and medical devices.

The sale of the Healthcare Trade business supports Oriola-KD's strategy to focus
on pharmaceutical wholesale and retail businesses. According to the agreement
all Oriola-KD's Healthcare Trade businesses in Finland, Sweden, Denmark,
Estonia, Latvia and Lithuania will be transferred to Mediq at the time of
closing, which is expected to take place May 31, 2010. Mediq will pay EUR 85
million in cash for the acquisition to Oriola-KD at time of the closing.
Oriola-KD will record a profit of approximately EUR 60 million from the sale of
the business.

Oriola-KD's Healthcare Trade business markets, sells and services medical and
laboratory products in Finland, Sweden, Denmark, Estonia, Latvia and Lithuania.
It also provides logistics services for healthcare service providers in Sweden.
The net sales in 2009 were EUR 145.1 million (EUR 155.2 million) and operating
profit EUR 8.9 million (EUR 7.9 million). The business has currently some 440
employees."We have invested in line with our strategy into the development of the Russian
and Swedish pharmaceutical wholesale and retail businesses and consequently our
resources to develop the Healthcare Trade businesses have been limited. This
transaction enables Oriola-KD to focus on pharmaceutical retail and wholesale
businesses with increased financial resources to develop and grow especially in
Russia and Sweden," said Eero Hautaniemi, President and CEO of Oriola-KD
Corporation."The acquisition is a logical next step in our international growth strategy.
Oriola-KD's Healthcare Trade business is a perfect addition to our existing
direct and institutional business. Due to the similarity to our existing
business we see a large potential for synergies and growth. Together we will
form a strong team in the Nordics and Baltics," said Marc van Gelder, CEO,
Mediq.

About Oriola-KD Corporation

Oriola-KD Corporation is a leading pharmaceutical wholesale and retail company
in Finland, Sweden, Russia and the Baltic countries.

About Mediq:

Mediq is an international company delivering pharmaceuticals, medical supplies
and related care services. The patient is at the center of everything we do.
Mediq delivers via three channels: direct to people's homes (Mediq Direct), via
hospitals, nursing homes and other healthcare institutions (Mediq Institutional)
and via Mediq Pharmacies. Mediq operates in 14 countries: the Netherlands,
Poland, the United States, Denmark, Germany, Norway, Sweden, Finland, Hungary,
Switzerland, Belgium, Estonia, Latvia and Lithuania. Its head office is located
in Utrecht, the Netherlands. The company was founded in 1899 and has around
8,200 employees. Mediq is listed on Euronext Amsterdam. For more information see
www.mediq.com.


Oriola-KD Corporation

Eero Hautaniemi
President and CEO


Kimmo Virtanen
Executive Vice President and CFO


Further information:

Kimmo Virtanen
Executive Vice President and CFO
tel. +358 (0)10 429 2069
e-mail: kimmo.virtanen@oriola-kd.com

Pellervo Hämäläinen
Vice President, Communications and Investor Relations
tel. +358 (0)10 429 2497
e-mail: pellervo.hamalainen@oriola-kd.com
Eero Hautaniemi
President and CEO
tel. +358 (0)10 429 2109
e-mail: eero.hautaniemi@oriola-kd.com

Distribution
NASDAQ OMX Helsinki Ltd
Principal media

Published by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
www.oriola-kd.com


[HUG#1414999]